For financial assistance for development and commercialisation of Dengue Tetravalent Vaccine
Panacea Biotec has signed agreement with Technology Development Board, Govt. of India for providing financial assistance of Rs 28.99 crore for the development and commercialisation of Dengue Tetravalent Vaccine (Live Attenuated, Recombinant, Lycophilized).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
